Strata Skin Scien (SSKN) Stock Price, Quote & News

Company Profile

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company offers XTRAC excimer laser and VTRAC lamp systems, which are used in the treatment of psoriasis, vitiligo, and other...

Industry: Medical Devices

Sector: Healthcare

Phone: 215 619 3200

Fax: 215 619 3209

Website: www.strataskinsciences.com

Address:

5 Walnut Grove Drive, Suite 140, Horsham, United States

roaringlions100 Oct. 24 at 1:59 PM

$SSKN vcig! Going to 1000 set limits and join

0 · Reply

GDS_investing Oct. 21 at 1:45 PM

$SSKN and more great news out: "STRATA Skin Sciences Reinforces Market Leadership Following Key Litigation Milestones Against LaserOptek" The market cap is still 10m, that's ridiculous. https://strataskinsciencesinc.gcs-web.com/news-releases/news-release-details/strata-skin-sciences-reinforces-market-leadership-following-key

0 · Reply

roaringlions100 Oct. 20 at 3:39 AM

$SUGP $SSKN extremely undervalued at 200%ctb

0 · Reply

ValueVester Oct. 19 at 12:06 PM

$SSKN Buy value. Strata is trading at .03x current sales. Most medical device companies trade at 3x sales. Do the math. SSKN is undervalued. Should be 90mil on market cap. That would be $17/share. Once CMS updates the CPT codes revenue should get closer to 50mil per year. At 3x 50mil in sales price per share would be $28. Seemingly far off, but that is the math.

0 · Reply

roaringlions100 Oct. 17 at 11:55 AM

$SSKN 2.70 getting knocked out!

0 · Reply

Bellbent Oct. 17 at 2:23 AM

$SSKN not so happy https://www.tipranks.com/news/company-announcements/strata-skin-sciences-announces-equity-distribution-agreement

0 · Reply

roaringlions100 Oct. 16 at 5:42 PM

$BTC.X $SSKN !!! Low float 200% ctb and 0 shares available if you grab it limit it high she’s going to blow

0 · Reply

roaringlions100 Oct. 16 at 5:37 PM

$SSKN 0 shares available and over 200% ctb

0 · Reply

roaringlions100 Oct. 16 at 3:45 PM

$SSKN shorts keep adding next pop will go over 2.60

0 · Reply

roaringlions100 Oct. 16 at 3:10 PM

$SSKN big shake for the big run !

0 · Reply

Excimer Laser Demonstrates Promising Results in Treating Rare Variant of Cutaneous Lymphoma, Mycosis Fungoides

Oct 3, 2025, 10:50 AM EDT - 22 days ago

Marking Eczema Awareness Month – Clinical Research Validates Strata Skin Sciences' XTRAC® Excimer Laser as a Breakthrough Therapy for Localized Atopic Dermatitis

Sep 30, 2025, 8:15 AM EDT - 25 days ago

STRATA Skin Sciences Receives Continued Validation for its Personalized Approach with New Published Study Highlighting XTRAC® Excimer Laser Treatment Combined with a Topical Drug in Psoriasis

Sep 22, 2025, 8:15 AM EDT - 4 weeks ago

New Peer Reviewed Publication of Combination Therapy in Vitiligo with STRATA Skin Sciences' Excimer Laser and JAK Inhibitors Demonstrated Superior Safety and Unprecedented Response Rates, Providing Continued Validation of Personalized Medicine Approach

Sep 4, 2025, 4:05 PM EDT - 7 weeks ago

STRATA Skin Sciences Announces Closing of $2.42 Million Registered Direct Offering

Sep 4, 2025, 8:15 AM EDT - 7 weeks ago

STRATA Skin Sciences' Elevate 360 Consulting Offering Drives Growth in Partner Clinic Operations and Fuels New Partnership Agreements

Aug 13, 2025, 9:14 PM EDT - 2 months ago

STRATA Skin Sciences, Inc. (SSKN) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 8:15 AM EDT - 2 months ago

STRATA Skin Sciences Moves to Accelerate Medicare and Private Payer Coverage from Expanded CPT Code Expansion, Tripling Addressable Market to 30M+ Patients

Jul 31, 2025, 8:15 AM EDT - 3 months ago

STRATA Skin Sciences to Report Second Quarter 2025 Financial Results on August 13, 2025 and Provide Corporate Update

May 14, 2025, 7:39 PM EDT - 5 months ago

STRATA Skin Sciences, Inc. (SSKN) Q1 2025 Earnings Call Transcript

May 14, 2025, 4:05 PM EDT - 5 months ago

STRATA Skin Sciences Reports First Quarter 2025 Financial Results and Provides a Corporate Update

May 8, 2025, 8:15 AM EDT - 6 months ago

STRATA Skin Sciences to Participate in the D. Boral Capital Inaugural Global Conference

May 7, 2025, 8:15 AM EDT - 6 months ago

STRATA Skin Sciences to Report First Quarter 2025 Financial Results on May 14, 2025 and Provide Corporate Update

Mar 27, 2025, 10:51 PM EDT - 7 months ago

STRATA Skin Sciences, Inc. (SSKN) Q4 2024 Earnings Call Transcript

Mar 27, 2025, 4:05 PM EDT - 7 months ago

STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Corporate Update

Mar 21, 2025, 1:43 PM EDT - 7 months ago

STRATA Skin Sciences to Report Fourth Quarter and Year End 2024 Financial Results on March 27, 2025 and Provide Corporate Update

Mar 20, 2025, 8:25 AM EDT - 7 months ago

STRATA Skin Sciences Highlights New Clinical Study from Japan Demonstrating Superiority of Narrow Band Excimer Laser Over Non Narrow Band UVB-Source Like Excimer Light

Dec 5, 2024, 8:15 AM EST - 11 months ago

STRATA Skin Sciences to Participate in the Benchmark Company 13th Annual Discovery Investor Conference

Nov 13, 2024, 8:05 PM EST - 1 year ago

STRATA Skin Sciences, Inc. (SSKN) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 4:05 PM EST - 1 year ago

STRATA Skin Sciences Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

Nov 11, 2024, 8:15 AM EST - 1 year ago

STRATA Skin Sciences Announces Favorable Court Order in Complaint Against LaserOptek, Monarch Laser Services, and The Pinnacle Health Group

Nov 6, 2024, 8:15 AM EST - 1 year ago

STRATA Skin Sciences to Report Third Quarter 2024 Financial Results on November 13, 2024 and Provide Corporate Update

Oct 15, 2024, 8:15 AM EDT - 1 year ago

STRATA Skin Sciences' XTRAC® Excimer Laser was Focus of Two Lectures at Major Japanese Annual Dermatology Conference

Oct 8, 2024, 8:15 AM EDT - 1 year ago

STRATA Skin Sciences to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

Sep 17, 2024, 8:15 AM EDT - 1 year ago

STRATA Skin Sciences to Present at the iAccess Alpha - Buyside Best Ideas Fall Conference 2024

Sep 5, 2024, 8:15 AM EDT - 1 year ago

STRATA Skin Sciences to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth Conference

Sep 3, 2024, 8:15 AM EDT - 1 year ago

STRATA Skin Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 14, 2024, 10:26 PM EDT - 1 year ago

STRATA Skin Sciences, Inc. (SSKN) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 4:05 PM EDT - 1 year ago

STRATA Skin Sciences Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

Aug 7, 2024, 8:15 AM EDT - 1 year ago

STRATA Skin Sciences to Report Second Quarter 2024 Financial Results on August 14, 2024 and Provide Corporate Update

Aug 6, 2024, 8:15 AM EDT - 1 year ago

STRATA Skin Sciences to Participate in the 9th Annual Virtual Needham MedTech & Diagnostics 1x1 Conference

Jun 7, 2024, 8:15 AM EDT - 1 year ago

STRATA Skin Sciences' TheraClear®X Acne Therapy System Found to be Safe and Effective for Acne Lesions Across All Fitzpatrick Skin Types with Favorable Tolerability and Patient Satisfaction as Published in Peer Reviewed Journal

Jun 4, 2024, 8:00 AM EDT - 1 year ago

STRATA Skin Sciences to Participate in June Dermatology Conferences

May 15, 2024, 10:08 PM EDT - 1 year ago

STRATA Skin Sciences, Inc. (SSKN) Q1 2024 Earnings Call Transcript

May 15, 2024, 4:05 PM EDT - 1 year ago

STRATA Skin Sciences Reports First Quarter 2024 Financial Results and Provides a Corporate Update

May 14, 2024, 8:15 AM EDT - 1 year ago

STRATA Skin Sciences Surpasses 100 Domestic Installations of TheraClear®X Devices as of March 31, 2024

May 13, 2024, 4:30 PM EDT - 1 year ago

STRATA Skin Sciences to Participate in the Benchmark Healthcare House Call Virtual 1x1 Investor Conference

May 8, 2024, 8:15 AM EDT - 1 year ago

STRATA Skin Sciences to Report First Quarter 2024 Financial Results on May 15, 2024 and Provide Corporate Update

Apr 30, 2024, 8:15 AM EDT - 1 year ago

STRATA Skin Sciences Announces XTRAC® Comeback Placements in the First Quarter of 2024

Apr 26, 2024, 5:20 PM EDT - 1 year ago

STRATA Skin Sciences Announces 1-for-10 Reverse Stock Split

Apr 23, 2024, 8:30 AM EDT - 1 year ago

STRATA Skin Sciences to Present at the Planet MicroCap Showcase: Vegas 2024

Apr 9, 2024, 8:30 AM EDT - 1 year ago

STRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and Japan

Mar 27, 2024, 10:03 PM EDT - 1 year ago

STRATA Skin Sciences, Inc. (SSKN) Q4 2023 Earnings Call Transcript

Mar 27, 2024, 4:01 PM EDT - 1 year ago

STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 Earnings

Mar 13, 2024, 8:00 AM EDT - 1 year ago

STRATA Skin Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024

Mar 7, 2024, 8:00 AM EST - 1 year ago

STRATA Skin Sciences Announces Initiative to Expand Treatment Coverage

Feb 26, 2024, 4:01 PM EST - 1 year ago

STRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap Financial

Dec 29, 2023, 8:00 AM EST - 1 year ago

STRATA Skin Sciences Announces Expansion of Distribution Agreement with Kosmo Meditech

Dec 4, 2023, 8:00 AM EST - 2 years ago

STRATA Skin Science Announces Strengthening of Leadership Team

Dec 1, 2023, 8:00 AM EST - 2 years ago

STRATA Skin Sciences to Participate in the Benchmark 12th Annual Discovery One-on-One Investor Conference

roaringlions100 Oct. 24 at 1:59 PM

$SSKN vcig! Going to 1000 set limits and join

0 · Reply

GDS_investing Oct. 21 at 1:45 PM

0 · Reply

roaringlions100 Oct. 20 at 3:39 AM

$SUGP $SSKN extremely undervalued at 200%ctb

0 · Reply

ValueVester Oct. 19 at 12:06 PM

0 · Reply

roaringlions100 Oct. 17 at 11:55 AM

$SSKN 2.70 getting knocked out!

0 · Reply

Bellbent Oct. 17 at 2:23 AM

$SSKN not so happy https://www.tipranks.com/news/company-announcements/strata-skin-sciences-announces-equity-distribution-agreement

0 · Reply

roaringlions100 Oct. 16 at 5:42 PM

$BTC.X $SSKN !!! Low float 200% ctb and 0 shares available if you grab it limit it high she’s going to blow

0 · Reply

roaringlions100 Oct. 16 at 5:37 PM

$SSKN 0 shares available and over 200% ctb

0 · Reply

roaringlions100 Oct. 16 at 3:45 PM

$SSKN shorts keep adding next pop will go over 2.60

0 · Reply

roaringlions100 Oct. 16 at 3:10 PM

$SSKN big shake for the big run !

0 · Reply

PennyGod1759 Oct. 16 at 2:49 PM

$SSKN now they’re running to buy 🚀 🚀 🚀

0 · Reply

OJ_ATX Oct. 16 at 2:26 PM

$SSKN Let's go.

0 · Reply

DylanGFM Oct. 16 at 2:15 PM

$WHWK $ELWS $ELAB $NUAI $SSKN

0 · Reply

PennyGod1759 Oct. 16 at 2:09 PM

$SSKN squeeze incoming 🚀🚀🚀🚀🚀

0 · Reply

Bellbent Oct. 16 at 1:54 PM

$SSKN SHORTS GOT CAUGHT HERE!

0 · Reply

dbr_island Oct. 16 at 1:48 PM

NUAI changed so many lives with this call👇🏆 TKLF could be $10+ I tell you 🎯✅🚨🚨🚨 Stop ignoring smart money!!!! $LOBO $PRAX $CTOR $SBFM $SSKN lets get it

0 · Reply

Bellbent Oct. 16 at 1:46 PM

$SSKN No offering! Also given a Nasdaq extension! This should squeeze! Nobody with half a brain would be crazy enough to hold a short here over the weekend! Good news ALWAYS comes at the first of the week! PT10

0 · Reply

Dani_G_German Oct. 16 at 1:40 PM

$SSKN anything under two was a steal

0 · Reply

Bellbent Oct. 16 at 12:10 PM

$SSKN who gives a rats #_\ if we get an offering, its still dirt cheap and will be sold here very soon. Too much good news going on here for this crazy evaluation

0 · Reply

Bellbent Oct. 15 at 11:04 PM

$SSKN shit everyone is betting on a 2 dollar offering tomorrow. I've seen them pump after an offering but shorts might know more then I do, the 2 dollar EOD is suspect. May be the same old playbook. GLTAL

0 · Reply

Dani_G_German Oct. 15 at 10:26 PM

$SSKN in with a 500 starter. 🐠

0 · Reply

roaringlions100 Oct. 15 at 8:54 PM

$SSKN 218% ctb almost climbed 100% on ctb and price has played flat on the day 3.00 to 5.00 range easy if they cover

0 · Reply

Market Cap	8.96M
Revenue (ttm)	33.56M
Net Income (ttm)	-10.09M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-30.07%
Debt to Equity Ratio	49.26

Volume	116,200
Avg Vol	5,795,606
Day's Range	N/A - N/A
Shares Out	5.27M
Stochastic %K	16%
Beta	0.50
Analysts	Strong Sell
Price Target	$8.00